First Quarter 2026 H.B. Fuller Earnings Conference Call 1200 Willow Lake Blvd, St Paul, Minnesota 55110 www.hbfuller.com March 26, 2026 Disclosure Safe Harbor Statement Certain matters discussed today are forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements reflect our current expectations, and actual results may differ as they are subj ...

For the quarter ended February 2026, H. B. Fuller (FUL) reported revenue of $770.84 million, down 2.3% over the same period last year. EPS came in at $0.57, compared to $0.54 in the year-ago quarter.The reported revenue represents a surprise of -2.44% over the Zacks Consensus Estimate of $790.1 million. With the consensus EPS estimate being $0.56, the EPS surprise was +2.39%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stree ...

Wall Street analysts forecast that H. B. Fuller (FUL) will report quarterly earnings of $0.56 per share in its upcoming release, pointing to a year-over-year increase of 3.7%. It is anticipated that revenues will amount to $790.1 million, exhibiting an increase of 0.2% compared to the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of t ...

Group 1 - Ecolab Inc. has been upgraded to Buy from Hold by Berenberg, with a new price target of $326, up from $300 [1] - Berenberg plans to implement a 10%-14% price increase across all products and services, viewing Ecolab as a net inflation beneficiary [1][2] - Ecolab reaffirmed its commitment to secure supply and service amid rising global energy costs, announcing a global energy surcharge effective April 1, 2026 [2] Group 2 - Ecolab provides hygiene, water, and infection prevention solutions, with specialized products offered through its Global Institutional & Specialty and Global Healthcare & Life Sciences segments [3]

Core Insights - Reckitt Benckiser Group PLC is undergoing a strategic turnaround focused on growth and improved execution in the consumer goods sector, competing with Procter & Gamble and Unilever [1] Financial Performance - Deutsche Bank maintains a "Hold" rating for Reckitt Benckiser with a stock price of $15.74 and raised its price target to 5,700 GBp, indicating a cautiously optimistic outlook [2][6] - RBC Capital Markets increased its price target from £60 to £64, maintaining an outperform rating, supported by Reckitt's consistent mid-single-digit growth and the "Fuel for Growth" plan [3][6] - Reckitt's shares are currently valued at approximately 18 times earnings for 2026, compared to around 20 times for the broader European consumer sector, despite a 17% increase in share price this year [4][6] Growth Prospects - Emerging markets for Reckitt are expected to achieve double-digit organic growth in 2025, contributing positively to the company's outlook [4] - The divestment of the Essential Home and Mead Johnson Nutrition units is anticipated to enhance management's focus on core operations [5]

Core Viewpoint - Seaport Global Securities upgraded HB Fuller from Neutral to Buy with a price target of $80.00, resulting in a pre-market share increase of over 1% [1] Financial Performance - HB Fuller is expected to achieve strong year-on-year EBITDA growth in fiscal 2025 despite sluggish demand, driven by margin expansion from lower costs and mix improvements [2] - The EBITDA margin increased by 110 basis points year-over-year, even with declining volumes, indicating effective execution in pricing, procurement, portfolio restructuring, and manufacturing optimization [2] Segment Performance - The Engineering Adhesives segment led growth with a 14% EBITDA increase, while Building Adhesive Solutions outperformed underlying markets, benefiting from data center construction demand and growth in the Middle East [3] - The Hygiene, Health & Consumables segment showed weakness but was partially offset by demand from medical applications [3] Future Projections - Seaport projects an additional $25 million in price/cost tailwinds for FY26 and approximately $70 million in optimization benefits through FY30 [4] - The current valuation at 7.8x forward EBITDA is below the 3-year average of 9.0x, supporting the upgrade [4]

Third Quarter 2025 Conference Call September 25, 2025 ® 2025 H.B. Fuller Title Slide Disclosure ® 2025 H.B. Fuller Third Quarter Highlights Adjusted EBITDA $171M Up 3% YOY Adjusted EBITDA Margin 19.1% Up 110 bps YOY Safe Harbor Statement Certain matters discussed today are forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements reflect our ...

Core Insights - H. B. Fuller (FUL) is expected to report quarterly earnings of $1.24 per share, reflecting a 9.7% increase year-over-year, while revenues are forecasted at $891.95 million, indicating a decline of 2.8% compared to the previous year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, suggesting analysts have reassessed their projections [1] Revenue Projections - Analysts project 'Net Revenue- Hygiene, Health and Consumable Adhesives' to reach $397.69 million, representing a year-over-year increase of 2% [4] - 'Net Revenue- Construction Adhesives' is expected to be $232.65 million, indicating a significant year-over-year increase of 51.9% [4] - 'Net Revenue- Engineering Adhesives' is forecasted at $265.33 million, suggesting a year-over-year decline of 29.2% [4] Stock Performance - H. B. Fuller shares have increased by 3.9% over the past month, outperforming the Zacks S&P 500 composite, which rose by 3% [4] - The company holds a Zacks Rank of 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [4]

Core Insights - Procter & Gamble (P&G) is set to announce its earnings on July 29, 2025, with historical data indicating a strong likelihood of positive one-day returns post-announcement, occurring in 70% of cases [2][6] - The analysts' consensus for the upcoming quarter is earnings of $1.42 per share on revenues of $20.85 billion, reflecting modest growth expectations compared to the previous year's earnings of $1.40 per share on revenues of $20.53 billion [3] - P&G currently has a market capitalization of approximately $372 billion, with $84 billion in revenue over the past year, $20 billion in operating profits, and a net income of $15 billion [4] Historical Performance - Over the last five years, P&G has recorded 20 earnings data points, with 14 positive and 6 negative one-day returns, resulting in a median increase of 2.2% for positive returns and a median decrease of -2.9% for negative returns [6] - The probability of positive one-day returns drops to 67% when considering the last three years instead of five [6] Trading Strategies - Traders can utilize historical trends to position themselves ahead of earnings releases or analyze post-earnings returns to inform their trading strategies [5][7] - A strategy based on the correlation between short-term and medium-term returns can be effective, particularly if the 1D and 5D returns show a strong correlation [7][8]

Financial Performance - Adjusted EBITDA and Adjusted EPS increased by 5% year-over-year[6] - Adjusted gross margin increased by 110 bps to 32.2% due to cost savings, acquisitions/divestitures, and pricing actions[6] - Adjusted EBITDA margin increased by 130 bps year-over-year to 18.4%[6] - Q2 2025 adjusted EBITDA increased 5% year-over-year to $166 million[16] - Q2 2025 adjusted EPS increased 5% year-over-year to $1.18, driven by higher adjusted net income and lower shares outstanding[16] Revenue and Organic Growth - Organic revenue increased by 0.4% year-over-year[16] - Expect fiscal year 2025 net revenue to be down 2% to 3%[18] - Expect fiscal year 2025 organic revenue to be flat to up 2% year-over-year[18] Segment Performance - Hygiene, Health, and Consumable Adhesives organic revenue increased 1.7% year-over-year, with an adjusted EBITDA margin of 15.6%[9] - Engineering Adhesives organic revenue declined 0.4% year-over-year, but adjusted EBITDA margin increased 310 bps year-over-year to 22.9%[9] - Building Adhesive Solutions organic sales decreased 0.9% year-over-year, but adjusted EBITDA margin expanded 60 bps year-over-year to 16.7%[9] Financial Guidance - Expect fiscal year 2025 adjusted EBITDA to be in the range of $615 million to $630 million, representing a 4% to 6% increase year-over-year[18] - Expect fiscal year 2025 adjusted EPS to be in the range of $4.10 to $4.30, representing growth of 7% to 12% year-over-year[18]